Monitoring Agency Report

EPACK PREFAB TECHNOLOGIES LIMITED (Previously known as EPACK Prefab Technologies Private Limited and EPACK Polymers Private Limited) 8th Floor, Plot No 51-52, Riana Aureus, Sector 136, Gautam Buddha Nagar, Noida, U.P. India 201305 +91-81304 44466 info@epack.in www.epackprefab.com ISO 9001 & ISO 14001 Certified CIN : L74999UP1999PLC116066 November 04, 2026 National Stock Exchange of India Limited BSE Limited Listing Department Listing Department Exchange Plaza, C-1 Block G, Bandra Kurla Corporate Relationship Department Complex Bandra [E], Mumbai – 400051 Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400001 NSE Scrip Symbol: EPACKPEB BSE Scrip Code: 544540 ISIN: INE0MLS01022 ISIN: INE0MLS01022 Sub: Submission of Monitoring Agency Report for the quarter ended September 30, 2026 Dear Sir/ Ma’am, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) and read with Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”), please find enclosed the Monitoring Agency Report for the quarter ended September 30, 2026 issued by CARE Ratings Limited, Monitoring Agency, appointed for monitoring the utilization of proceeds of the Initial Public Issue (IPO) of the Company. The above information will also be hosted on the website of the Company at https://epackprefab.com/investor-relations/. Kindly take the same on record. Thanking You, For EPACK Prefab Technologies Limited Khushboo Mishra Company Secretary and Compliance Officer Encl.: as above Registered Office: 61 – B, Udyog Vihar, Surajpur- Kasna Road, Greater Noida, Gautam Buddha Nagar, Uttar Pradesh – 201306, India THINK PREFAB THINK EPACK No. CARE/NRO/GEN/2026-27/1158 The Board of Directors Epack Prefab Technologies Limited 61-B, Udyog Vihar Surajpur, Kasna Road, Gautam Buddha Nagar, Greater Noida, Uttar Pradesh, India-201306 November 04,2026 Monitoring Agency Report for the quarter ended September 30, 2026-in relation to the IPOof Epack Prefab Technologies We write in our capacity of Monitoring Agency for the IPO for the amount aggregating to Rs. 300 crore of the Company and refer to our duties cast under 41of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated September 15, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Sahil Goyal Associate Director Sahil.goyal@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Noida, Off Eastern Express Highway, Sion (East), Mumbai - Gautam Budh Nagar, Uttar Pradesh -201301 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: EpackPrefab TechnologiesLimited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: No deviation (Refer note below) (b) Range of Deviation:NA Note: During Q2FY27, the Company utilized Rs. 32.26 crore from the IPO proceeds, comprising Rs. 25.93 crore utilized through the Monitoring Account and Rs. 6.33 crore utilizedthrough the Current Account. Utilization from the Current Account resulted in a comingling of funds, whereby IPO proceeds were mixed with other operational cash flows, owing to usage from current account. The current account utilization during the quarter primarily comprised Rs. 1.01 crore towards the Ghiloth manufacturing facility project, Rs. 0.25 crore towards the Mambattu facility expansion project, and Rs. 5.07 crore towards General Corporate Purposes. In view of the above, we have relied upon the Management Utilization Certificate and CA Certificate provided by the management for verification of the utilization and nature of the aforesaid transactions routed through the Current Account. Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal inany security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict ofinterest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments,where CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Noida, Off Eastern Express Highway, Sion (East), Mumbai - Gautam Budh Nagar, Uttar Pradesh -201301 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 CIN-L67190MH1993PLC071691 submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, a Management/Board. Signature: Name and designation of the Authorized Signatory: Sahil Goyal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Noida, Off Eastern Express Highway, Sion (East), Mumbai - Gautam Budh Nagar, Uttar Pradesh -201301 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 CIN-L67190MH1993PLC071691 Disclaimers to MA report: a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as ). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by the management /officials/ consultants of the Issuer and third-party sources like statutory auditor appointed by the Issuer believed by it to be accurate and reliable. c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any financial liabilities whatsoever to the users of this Report. d) The MA and its affili [Showing first 8,000 characters — download PDF for full document]